bioRxivCell Biology
Defining Cardiac Cell Populations and Relative Cellular Composition of the Early Fetal Human Heart
Abstract
The human heart is primarily composed of cardiomyocytes, fibroblasts, endothelial and smooth muscle cells. Reliable identification of fetal cardiac cell types using protein markers is important for understanding cardiac development and delineating the cellular composition of the human heart during early development, which remains largely unknown. The aim of this study was to use immunohistochemistry (IHC), flow cytometry and RT-PCR analyses to investigate the expression and specificity of commonly used cardiac cell markers in the early human fetal heart (8-12 post-conception weeks). The expression of previously reported protein markers for the detection of cardiomyocytes (Myosin Heavy Chain (MHC) and Troponin I (cTnI)), fibroblasts (DDR2, Thy1, Vimentin), endothelial cells (CD31) and smooth muscle cells (-SMA) were assessed. Flow cytometry revealed two distinct populations of cTnI expressing cells based on fluorescence intensity: cTnIHigh and cTnILow. MHC positive cardiomyocytes were cTnIHigh, whereas MHC negative non-myocyte cells were cTnILow. cTnI expression in non-myocytes was further confirmed by IHC and RT-PCR analyses, suggesting troponins are not cardiomyocyte-specific and may play distinct roles in non-muscle cells during early development. Vimentin was confirmed to be enriched in cultured fibroblast populations and flow cytometry revealed VimHigh and VimLow cell populations in the fetal heart. MHC positive cardiomyocytes were VimLow whilst CD31 positive endothelial cells were VimHigh. Based on the markers investigated, we estimate fetal human cardiomyocyte populations comprise 75-80% of total cardiac cells and exhibit the following marker profile: -MHC+/cTnIHigh/VimLow. For the non-cardiomyocyte population, we estimate they comprise 20-25% of total cardiac cells and exhibit the following marker profile: -MHC-/cTnILow/VimHigh. Our study suggests the marker profiles and proportions of fetal cardiac populations are distinct from that of the adult heart.
- organism: human
- assay: protein sequence
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High cardiomyocyte diversity in human early prenatal heart development
Christer Sylvén, Eva Wärdell, … Stefania Giacomello·iSciencePeer-reviewed·Dec 20, 2022
- Cells and gene expression programs in the adult human heart
Monika Litviňuková, Carlos N. Talavera-López, … Sarah Amalia Teichmann·bioRxiv·Apr 3, 2020
- A human developing heart atlas reveals cardiovascular cell diversity for in vitro model benchmarking
Vincent R. Knight-Schrijver, Semih Bayraktar, … Sanjay Sinha·bioRxiv·Apr 27, 2024
- HSA+ immature cardiomyocytes persist in the adult heart and expand after ischemic injury
Mariana Valente, Tatiana Pinho Resende, … Perpétua Pinto‐do‐Ó·PLoS BiologyPeer-reviewed·Jun 27, 2019
- Spatial Dynamics of the Developing Human Heart
Enikő Lázár, Raphaël Mauron, … Joakim Lundeberg·Nature GeneticsPeer-reviewed·Oct 29, 2025
- ETV2 upregulation marks the specification of early cardiomyocytes and endothelial cells during co-differentiation
Xu Cao, Maria Mircea, … Valeria V. Orlova·Stem CellsPeer-reviewed·Dec 12, 2022